2012
We started our pharmaceutical consulting business to support Pharmacovigilance, regulatory, and quality management services. With a cumulative 20+ years of experience, we have solved complex regulatory problems and implemented multiple regulatory and pharmacovigilance solutions across the worldwide pharmaceutical business.
2019
Clydesdale Pharma was founded and incorporated in Unit-3 Campbell Court, Tadley. The company obtained its authorisation from MHRA to distribute pharmaceutical products from its facility in Tadley. With this, the company prepared its first quality management system.
2020
Clydesdale Pharma extended its operation by obtaining the GMP certification for its Unit-4 Campbell Court facility in Tadley with the intention to perform analytical testing activities as well as importation and batch release from the facility. Additionally, the company acquired several UK generic licenses to distribute them in the UK.
2022
Clydesdale extended its business operation to include unit-5 Campbell Court, Tadley and successfully launched the generic products in the UK. Furthermore, the company extended its operation to supply goods to the NHS hospitals along with distributing them to the country's nationwide pharmacy stores.
2024
The company is looking to extend the operation to include Unit-11 Campbell Court for its operation, additionally to launch furthermore products.